GPX4 and breast cancer: Treatment with mitoTEMPO also mitigated the NR-mediated decrease of GPX4 and the accumulation of pH2AX protein (Figure 5e), finally demonstrating the implication of mitochondria in promoting DNA damage and ferroptosis in BC cells.